Rocket Pharmaceuticals 2023 J.P. Morgan Healthcare Conference

Rocket Pharmaceuticals presented at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023. The company outlined its pipeline of first-in-class and best-in-class gene therapies targeting rare genetic diseases including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease.